• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin

tetano

Editor, Senior Moderator
Elife. 2018 Sep 6;7. pii: e38795. doi: 10.7554/eLife.38795. [Epub ahead of print]
[h=1]Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin.[/h] Phillips AM[SUP]1[/SUP], Doud MB[SUP]2[/SUP], Gonzalez LO[SUP]3[/SUP], Butty VL[SUP]4[/SUP], Lin YS[SUP]5[/SUP], Bloom JD[SUP]2[/SUP], Shoulders MD[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Herein, we systematically and quantitatively evaluate whether endoplasmic reticulum (ER) proteostasis factors impact the mutational tolerance of secretory pathway proteins. We focus on influenza hemagluttinin (HA), a viral membrane protein that folds in the host's ER via a complex pathway. By integrating chemical methods to modulate ER proteostasis with deep mutational scanning to assess mutational tolerance, we discover that upregulation of ER proteostasis factors broadly enhances HA mutational tolerance across diverse structural elements. Remarkably, this proteostasis network-enhanced mutational tolerance occurs at the same sites where mutational tolerance is most reduced by propagation at fever-like temperature. These findings have important implications for influenza evolution, because influenza immune escape is contingent on HA possessing sufficient mutational tolerance to evade antibodies while maintaining the capacity to fold and function. More broadly, this work provides the first experimental evidence that ER proteostasis mechanisms define the mutational tolerance and, therefore, the evolution of secretory pathway proteins.


[h=4]KEYWORDS:[/h] biochemistry; chemical biology; evolutionary biology; human; viruses

PMID: 30188321 DOI: 10.7554/eLife.38795
Free full text
 
Back
Top Bottom